BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 26321095)

  • 1. Serum N-glycan analysis in breast cancer patients--Relation to tumour biology and clinical outcome.
    Haakensen VD; Steinfeld I; Saldova R; Shehni AA; Kifer I; Naume B; Rudd PM; Børresen-Dale AL; Yakhini Z
    Mol Oncol; 2016 Jan; 10(1):59-72. PubMed ID: 26321095
    [TBL] [Abstract][Full Text] [Related]  

  • 2. N-glycan signatures identified in tumor interstitial fluid and serum of breast cancer patients: association with tumor biology and clinical outcome.
    Terkelsen T; Haakensen VD; Saldova R; Gromov P; Hansen MK; Stöckmann H; Lingjaerde OC; Børresen-Dale AL; Papaleo E; Helland Å; Rudd PM; Gromova I
    Mol Oncol; 2018 Jun; 12(6):972-990. PubMed ID: 29698574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exploring serum and immunoglobulin G N-glycome as diagnostic biomarkers for early detection of breast cancer in Ethiopian women.
    Gebrehiwot AG; Melka DS; Kassaye YM; Gemechu T; Lako W; Hinou H; Nishimura SI
    BMC Cancer; 2019 Jun; 19(1):588. PubMed ID: 31208374
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum N-glycan profiles differ for various breast cancer subtypes.
    Vreeker GCM; Vangangelt KMH; Bladergroen MR; Nicolardi S; Mesker WE; Wuhrer M; van der Burgt YEM; Tollenaar RAEM
    Glycoconj J; 2021 Jun; 38(3):387-395. PubMed ID: 33877489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression.
    Abd Hamid UM; Royle L; Saldova R; Radcliffe CM; Harvey DJ; Storr SJ; Pardo M; Antrobus R; Chapman CJ; Zitzmann N; Robertson JF; Dwek RA; Rudd PM
    Glycobiology; 2008 Dec; 18(12):1105-18. PubMed ID: 18818422
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of 34 N-glycan isomers in human serum by capillary electrophoresis coupled with laser-induced fluorescence allows improving glycan biomarker discovery.
    Schwedler C; Kaup M; Weiz S; Hoppe M; Braicu EI; Sehouli J; Hoppe B; Tauber R; Berger M; Blanchard V
    Anal Bioanal Chem; 2014 Nov; 406(28):7185-93. PubMed ID: 25234305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Breast cancer diagnosis and prognosis through quantitative measurements of serum glycan profiles.
    Kyselova Z; Mechref Y; Kang P; Goetz JA; Dobrolecki LE; Sledge GW; Schnaper L; Hickey RJ; Malkas LH; Novotny MV
    Clin Chem; 2008 Jul; 54(7):1166-75. PubMed ID: 18487288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum immunoglobulin G Fc region N-glycosylation profiling by matrix-assisted laser desorption/ionization mass spectrometry can distinguish breast cancer patients from cancer-free controls.
    Kawaguchi-Sakita N; Kaneshiro-Nakagawa K; Kawashima M; Sugimoto M; Tokiwa M; Suzuki E; Kajihara S; Fujita Y; Iwamoto S; Tanaka K; Toi M
    Biochem Biophys Res Commun; 2016 Jan; 469(4):1140-5. PubMed ID: 26740182
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical utility of high-throughput glycome analysis in patients with pancreatic cancer.
    Nouso K; Amano M; Ito YM; Miyahara K; Morimoto Y; Kato H; Tsutsumi K; Tomoda T; Yamamoto N; Nakamura S; Kobayashi S; Kuwaki K; Hagihara H; Onishi H; Miyake Y; Ikeda F; Shiraha H; Takaki A; Nakahara T; Nishimura S; Yamamoto K
    J Gastroenterol; 2013 Oct; 48(10):1171-9. PubMed ID: 23307043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycoproteins in the Sera of Oncological Patients.
    Hernychová L; Uhrík L; Nenutil R; Novotný MV
    Klin Onkol; 2019; 32(Supplementum 3):39-45. PubMed ID: 31627705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Breast cancer diagnosis by analysis of serum N-glycans using MALDI-TOF mass spectroscopy.
    Lee SB; Bose S; Ahn SH; Son BH; Ko BS; Kim HJ; Chung IY; Kim J; Lee W; Ko MS; Lee K; Chang S; Park HS; Lee JW; Kim DC
    PLoS One; 2020; 15(4):e0231004. PubMed ID: 32271809
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Glycosylation in Indolent, Significant and Aggressive Prostate Cancer by Automated High-Throughput
    Gilgunn S; Murphy K; Stöckmann H; Conroy PJ; Murphy TB; Watson RW; O'Kennedy RJ; Rudd PM; Saldova R
    Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33287410
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Glycan gene expression signatures in normal and malignant breast tissue; possible role in diagnosis and progression.
    Potapenko IO; Haakensen VD; Lüders T; Helland A; Bukholm I; Sørlie T; Kristensen VN; Lingjaerde OC; Børresen-Dale AL
    Mol Oncol; 2010 Apr; 4(2):98-118. PubMed ID: 20060370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive N-Glycome Profiling of Cells and Tissues for Breast Cancer Diagnosis.
    Li Q; Li G; Zhou Y; Zhang X; Sun M; Jiang H; Yu G
    J Proteome Res; 2019 Jun; 18(6):2559-2570. PubMed ID: 30889355
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of IgG N-glycome profile in colorectal cancer progression by MALDI-TOF-MS.
    Liu S; Cheng L; Fu Y; Liu BF; Liu X
    J Proteomics; 2018 Jun; 181():225-237. PubMed ID: 29698801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Healthy human serum N-glycan profiling reveals the influence of ethnic variation on the identified cancer-relevant glycan biomarkers.
    Gebrehiwot AG; Melka DS; Kassaye YM; Rehan IF; Rangappa S; Hinou H; Kamiyama T; Nishimura SI
    PLoS One; 2018; 13(12):e0209515. PubMed ID: 30592755
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation.
    Arnold JN; Saldova R; Hamid UM; Rudd PM
    Proteomics; 2008 Aug; 8(16):3284-93. PubMed ID: 18646009
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Exploring Glycan Markers for Immunotyping and Precision-targeting of Breast Circulating Tumor Cells.
    Wang D; Liu X; Hsieh B; Bruce R; Somlo G; Huang J; Sambucetti L
    Arch Med Res; 2015 Nov; 46(8):642-50. PubMed ID: 26657044
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of N-glycosylation with breast carcinoma and systemic features using high-resolution quantitative UPLC.
    Saldova R; Asadi Shehni A; Haakensen VD; Steinfeld I; Hilliard M; Kifer I; Helland A; Yakhini Z; Børresen-Dale AL; Rudd PM
    J Proteome Res; 2014 May; 13(5):2314-27. PubMed ID: 24669823
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum N-glycan profiles in patients with intraductal papillary mucinous neoplasms of the pancreas.
    Akimoto Y; Nouso K; Kato H; Miyahara K; Dohi C; Morimoto Y; Kinugasa H; Tomoda T; Yamamoto N; Tsutsumi K; Kuwaki K; Onishi H; Ikeda F; Nakamura S; Shiraha H; Takaki A; Okada H; Amano M; Nishimura S; Yamamoto K
    Pancreatology; 2015; 15(4):432-8. PubMed ID: 26052067
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.